Verrica Pharmaceuticals Reports Q1 2026 Financial Results

What Happened

• On May 12, 2026, Verrica Pharmaceuticals Inc. (VRCA) announced its financial results for the quarter ended March 31, 2026 and filed a Current Report on Form 8-K (Item 2.02) to disclose those results. The company furnished the press release announcing the results as Exhibit 99.1 to the Form 8-K.

Key Details

• Filing date: May 12, 2026.
• Reporting period: Quarter ended March 31, 2026.
• Item disclosed: Results of operations and financial condition (Item 2.02).
• Press release furnished as Exhibit 99.1; interactive XBRL cover page included (Item 9.01 / Exhibit 104).

Why It Matters

• Quarterly results are a primary source for investors to evaluate Verrica’s recent earnings, revenue, cash position and operational trends. The Form 8-K and accompanying press release are the official, company-provided summaries of those figures and any related commentary.
• Investors should review the press release and any linked financial statements/XBRL data to assess the company’s current performance and update valuation or investment decisions accordingly.